Literature DB >> 7550252

Creatine and its application as an ergogenic aid.

P L Greenhaff1.   

Abstract

Phosphocreatine (PCr) availability is likely to limit performance in brief, high-power exercise because the depletion of PCr results in an inability to maintain adenosine triphosphate (ATP) resynthesis at the rate required. It is now known that the daily ingestion of four 5-g doses of creatine for 5 days will significantly increase intramuscular creatine and PCr concentrations prior to exercise and will facilitate PCr resynthesis during recovery from exercise, particularly in those individuals with relatively low creatine concentrations prior to feeding. As a consequence of creatine ingestion, work output during repeated bouts of high-power exercise has been increased under a variety of experimental conditions. The reduced accumulation of ammonia and hypoxanthine in plasma and the attenuation of muscle ATP degradation after creatine feeding suggest that the ergogenic effect of creatine is achieved by better maintaining ATP turnover during contraction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7550252     DOI: 10.1123/ijsn.5.s1.s100

Source DB:  PubMed          Journal:  Int J Sport Nutr        ISSN: 1050-1606


  13 in total

1.  Use of nutritional supplements by high school football and volleyball players.

Authors:  M A Mason; M Giza; L Clayton; J Lonning; R D Wilkerson
Journal:  Iowa Orthop J       Date:  2001

Review 2.  Adverse effects of creatine supplementation: fact or fiction?

Authors:  J R Poortmans; M Francaux
Journal:  Sports Med       Date:  2000-09       Impact factor: 11.136

Review 3.  Creatine and the creatine transporter: a review.

Authors:  R J Snow; R M Murphy
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

Review 4.  Nutrition for improved sports performance. Current issues on ergogenic aids.

Authors:  P M Clarkson
Journal:  Sports Med       Date:  1996-06       Impact factor: 11.136

Review 5.  Oral creatine supplementation and skeletal muscle metabolism in physical exercise.

Authors:  José L M Mesa; Jonatan R Ruiz; M Marcela González-Gross; Angel Gutiérrez Sáinz; Manuel J Castillo Garzón
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 6.  The role of creatine in the management of amyotrophic lateral sclerosis and other neurodegenerative disorders.

Authors:  Amy Cameron Ellis; Jeffrey Rosenfeld
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

7.  Presence of normal creatine in the muscle of a patient with a mutation in the creatine transporter: a case study.

Authors:  Gail J Pyne-Geithman; Ton J deGrauw; Kim M Cecil; Gail Chuck; Melissa A Lyons; Yukisato Ishida; Joseph F Clark
Journal:  Mol Cell Biochem       Date:  2004-07       Impact factor: 3.396

8.  The Effects of Low-Dose Creatine Supplementation Versus Creatine Loading in Collegiate Football Players.

Authors:  Nathan Wilder; Richard G. Deivert; Frederick Hagerman; Roger Gilders
Journal:  J Athl Train       Date:  2001-06       Impact factor: 2.860

9.  Short-term creatine supplementation does not improve muscle activation or sprint performance in humans.

Authors:  Ryuta Kinugasa; Hiroshi Akima; Akemi Ota; Atsutane Ohta; Katsumi Sugiura; Shin-Ya Kuno
Journal:  Eur J Appl Physiol       Date:  2003-10-22       Impact factor: 3.078

10.  Creatine supplementation induces alteration in cross-sectional area in skeletal muscle fibers of wistar rats under swimming training.

Authors:  Irlena M W Moura; Fernando Farias Dos Santos; José A A Moura; Rui Curi; Luiz C Fernandes
Journal:  J Sports Sci Med       Date:  2002-09-01       Impact factor: 2.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.